Table 3. Comparison of in vitro with in silico results from PCR-RFLP-ITS2 assay.
Species | Agarose gel fragment sizes (bp) | Bioinformatic prediction of fragment sizes (bp) | ||
---|---|---|---|---|
PCR product | PCR-RFLP | PCR product | PCR-RFLP | |
An. neomaculipalpus | 500 | 259, 165, 111 | 452 | 255, 136, 61 |
An. apicimacula lineage C (Caribbean) | 481 | 300, 150, 70 | 481 | 290, 130, 61 |
An. apicimacula lineage P (Pacific) | 480 | 390, 70 | 480 | 372, 61, 47 |
An. punctimacula s.s. | 397 | 334, 81 | 393 | 317, 76 |
An. calderoni | 394 | Uncut | 401 | Uncut |
An. malefactor | 399 | Uncut; 378, 313, 113 | 401; 396 | Uncut; 326, 70 |
An. mattogrossensis | 505 | 230, 80 | 464* | 213, 190, 61 |
An. peryassui | 500 | 300, 96 | 464* | 287, 116, 61 |
* An ITS2 variant of 463 bp was found that yielded 286, 116 and 61 bp in the in silico restriction analysis.
PCR: Polymerase Chain Reaction; RFLP: Restriction Fragment Length Polymorphisms; (bp): base pairs.